Apellis Pharmaceuticals gets grant for treatment of complement-mediated eye disorder with long-acting compstatin analog
Discover how Apellis Pharmaceuticals' patented method using long-acting compstatin analogs can effectively treat complement-mediated eye disorders like geographic atrophy.
Discover how Apellis Pharmaceuticals' patented method using long-acting compstatin analogs can effectively treat complement-mediated eye disorders like geographic atrophy.
What's Your Reaction?
